• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黏菌素增强抗生素联合用药对多重耐药肺炎克雷伯菌的杀菌活性:一种比较单一峰血清浓度下多种联合杀菌试验和时间杀菌法的体外模型

Colistin Increases the Cidal Activity of Antibiotic Combinations Against Multidrug-Resistant Klebsiella pneumoniae: An In Vitro Model Comparing Multiple Combination Bactericidal Testing at One Peak Serum Concentration and Time-Kill Method.

作者信息

Mezzatesta Maria Lina, Caio Carla, Gona Floriana, Zingali Tiziana, Salerno Iasmine, Stefani Stefania

机构信息

1 Section of Microbiology, Department of Biomedical and Biotechnological Sciences, University of Catania , Catania, Italy .

2 Department of Laboratory Medicine and Advanced Biotechnologies, Mediterranean Institute for Transplantation and Advanced Specialized Therapies (ISMETT) , Palermo, Italy .

出版信息

Microb Drug Resist. 2016 Jul;22(5):360-3. doi: 10.1089/mdr.2015.0160. Epub 2016 Feb 24.

DOI:10.1089/mdr.2015.0160
PMID:26909754
Abstract

The lack of treatment for multidrug-resistant (MDR) Enterobacteriaceae often leads to the use of double or triple antibiotic combinations to increase the option of clinical success. This study analyzes multiple combination bactericidal testing (MCBT) to screen double and triple antibiotic combinations, at standard peak serum concentration, for bactericidal activity against 21 MDR Klebsiella pneumoniae isolates. This method was compared with time-killing curves. The full bactericidal activity against all strains was obtained only by adding colistin. MCBT has a potential to become a rapid method for testing multiple antibiotic combinations for MDR microorganisms when colistin is used, providing clinicians with in vitro cidal data within 48 hr of strain isolation.

摘要

多重耐药(MDR)肠杆菌科细菌缺乏有效的治疗方法,这常常导致使用双联或三联抗生素组合,以提高临床治疗成功的几率。本研究分析了多重组合杀菌试验(MCBT),以筛选在标准血清峰值浓度下对21株多重耐药肺炎克雷伯菌具有杀菌活性的双联和三联抗生素组合。该方法与时间杀菌曲线进行了比较。仅通过添加黏菌素才能获得对所有菌株的完全杀菌活性。当使用黏菌素时,MCBT有可能成为一种快速检测多重耐药微生物多种抗生素组合的方法,可在菌株分离后48小时内为临床医生提供体外杀菌数据。

相似文献

1
Colistin Increases the Cidal Activity of Antibiotic Combinations Against Multidrug-Resistant Klebsiella pneumoniae: An In Vitro Model Comparing Multiple Combination Bactericidal Testing at One Peak Serum Concentration and Time-Kill Method.黏菌素增强抗生素联合用药对多重耐药肺炎克雷伯菌的杀菌活性:一种比较单一峰血清浓度下多种联合杀菌试验和时间杀菌法的体外模型
Microb Drug Resist. 2016 Jul;22(5):360-3. doi: 10.1089/mdr.2015.0160. Epub 2016 Feb 24.
2
Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.替加环素单独及联合黏菌素和美罗培南对产碳青霉烯酶肠杆菌科细菌(KPC)菌株的时间杀菌试验研究。
Int J Antimicrob Agents. 2011 Mar;37(3):244-7. doi: 10.1016/j.ijantimicag.2010.10.031. Epub 2011 Jan 13.
3
Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.通过体外时间杀菌实验评估用于产VIM和NDM的肺炎克雷伯菌的双联和三联抗生素组合。
Antimicrob Agents Chemother. 2014;58(3):1757-62. doi: 10.1128/AAC.00741-13. Epub 2014 Jan 6.
4
In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.黏菌素联合其他抗菌药物对耐黏菌素产KPC肺炎克雷伯菌血流分离株的体外活性及抗生素后效应
J Antimicrob Chemother. 2014 Jul;69(7):1856-65. doi: 10.1093/jac/dku065. Epub 2014 Mar 19.
5
In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.体外研究新型氨基糖苷类药物普拉佐米星单独及与黏菌素、美罗培南、磷霉素或替加环素联合对产碳青霉烯酶肠杆菌科菌株的活性。
Int J Antimicrob Agents. 2015 Dec;46(6):616-21. doi: 10.1016/j.ijantimicag.2015.07.021. Epub 2015 Sep 9.
6
Three Dimensional Checkerboard Synergy Analysis of Colistin, Meropenem, Tigecycline against Multidrug-Resistant Clinical Klebsiella pneumonia Isolates.多粘菌素、美罗培南、替加环素对耐多药临床肺炎克雷伯菌分离株的三维棋盘协同分析
PLoS One. 2015 Jun 11;10(6):e0126479. doi: 10.1371/journal.pone.0126479. eCollection 2015.
7
Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance.比较黏菌素、磷霉素和替加环素对产超广谱β-内酰胺酶肺炎克雷伯菌分离株或碳青霉烯类耐药株的协同作用。
J Microbiol Immunol Infect. 2017 Dec;50(6):931-939. doi: 10.1016/j.jmii.2016.12.008. Epub 2017 Jul 6.
8
Synergistic Combinations and Repurposed Antibiotics Active against the Pandrug-Resistant Klebsiella pneumoniae Nevada Strain.对全耐药肺炎克雷伯菌内华达菌株有效的协同组合及重新利用的抗生素
Antimicrob Agents Chemother. 2019 Aug 23;63(9). doi: 10.1128/AAC.01374-19. Print 2019 Sep.
9
Evaluation of antibacterial activities of colistin, rifampicin and meropenem combinations against NDM-1-producing Klebsiella pneumoniae in 24 h in vitro time-kill experiments.在体外24小时时间杀菌实验中评估黏菌素、利福平和美罗培南联合用药对产NDM-1肺炎克雷伯菌的抗菌活性。
J Antimicrob Chemother. 2016 Aug;71(8):2321-5. doi: 10.1093/jac/dkw213. Epub 2016 Jun 21.
10
Synergistic antibiotic combinations for colistin-resistant Klebsiella pneumoniae.用于耐黏菌素肺炎克雷伯菌的协同抗生素组合
Acta Microbiol Immunol Hung. 2013 Jun;60(2):201-9. doi: 10.1556/AMicr.60.2013.2.10.

引用本文的文献

1
Assessment of the in vitro activity of azithromycin niosomes alone and in combination with levofloxacin on extensively drug-resistant Klebsiella pneumoniae clinical isolates.评估阿奇霉素非诺体单独使用以及与左氧氟沙星联合使用对广泛耐药肺炎克雷伯菌临床分离株的体外活性。
Braz J Microbiol. 2021 Jun;52(2):597-606. doi: 10.1007/s42770-021-00433-2. Epub 2021 Jan 22.
2
Emergence of two novel sequence types (3366 and 3367) NDM-1- and OXA-48-co-producing K. pneumoniae in Italy.意大利出现两种新型 NDM-1 和 OXA-48 共产生的 K. pneumoniae 序列类型(3366 和 3367)。
Eur J Clin Microbiol Infect Dis. 2019 Sep;38(9):1687-1691. doi: 10.1007/s10096-019-03597-w. Epub 2019 Jun 5.
3
Successful ceftazidime-avibactam treatment of MDR-KPC-positive Klebsiella pneumoniae infection in a patient with traumatic brain injury: A case report.
头孢他啶-阿维巴坦成功治疗创伤性脑损伤患者的多重耐药KPC阳性肺炎克雷伯菌感染:一例报告
Medicine (Baltimore). 2017 Aug;96(31):e7664. doi: 10.1097/MD.0000000000007664.
4
Himatanthus drasticus Leaves: Chemical Characterization and Evaluation of Their Antimicrobial, Antibiofilm, Antiproliferative Activities.马鲁铁青树叶片:化学特征及其抗菌、抗生物膜、抗增殖活性的评估
Molecules. 2017 May 31;22(6):910. doi: 10.3390/molecules22060910.